Should we switch over to tolterodine in every child with non-neurogenic daytime urinary incontinence in whom oxybutynin failed?

YÜCEL, SELÇUK; Akkaya, E; Guntekin, E; Kukul, E; Danisman, A; Akman, S; Baykara, M

doi:10.1016/j.urology.2004.09.036

Should we switch over to tolterodine in every child with non-neurogenic daytime urinary incontinence in whom oxybutynin failed?

Atıf İçin Kopyala

YÜCEL S., Akkaya E., Guntekin E., Kukul E., Danisman A., Akman S., ...Daha Fazla

UROLOGY, cilt.65, sa.2, ss.369-373, 2005 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 65 Sayı: 2
Basım Tarihi: 2005
Doi Numarası: 10.1016/j.urology.2004.09.036
Dergi Adı: UROLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.369-373
Marmara Üniversitesi Adresli: Hayır

Özet

Objectives. To assess the clinical efficacy of tolterodine prescribed to children with non-neurogenic daytime urinary incontinence secondary to overactive bladder who had previously failed to improve with oral oxybutynin treatment and its relation to the side-effect profile and compliance status.